ORKA
Oruka Therapeutics, Inc.
77.30$
-2.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -14.3% | +0.0% | -16.7% | +20.0% | -16.7% | +320.0% | +4.8% | +0.0% | +9.1% | +4.2% | +4.0% | +0.0% | -38.5% | +6.3% | +11.8% | +42.1% | +3.7% | +0.0% | +3.6% | -3.4% | +3.6% | +0.0% | +0.0% | +3.4% | -23.3% | -17.4% | -36.8% | -266.7% | – | +0.0% | +18.8% | – | – | +53.6% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -180.0% | – | – | – | – | – | – | – | |
| – | +38.9% | -22.6% | -18.8% | -39.3% | -32.9% | -35.9% | -15.5% | +5.9% | -33.5% | -21.1% | +10.7% | -4.9% | +1.9% | +182.5% | +204.9% | -10.2% | +24.4% | -3.9% | +14.6% | -44.7% | -54.3% | -46.3% | -50.2% | +46.6% | -34.9% | +26.8% | -85.4% | +251.1% | +11,217.0% | +37.6% | +25.8% | -38.4% | +20.9% | +20.3% | -4.7% | +5.4% | +48.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +68.9% | +29.7% | +55.1% | -9.1% | -15.9% | +13.2% | +38.1% | +7.3% | -6.0% | – | |
| – | +26.9% | -19.5% | -4.0% | -35.5% | -22.3% | -23.0% | -8.1% | +15.6% | -15.6% | -17.6% | +2.4% | +4.9% | -2.4% | +53.0% | +160.2% | -20.1% | +17.9% | -2.7% | +20.5% | -42.5% | -26.1% | -27.7% | -10.4% | +13.7% | +10.0% | -1.9% | -17.8% | +57.2% | +772.6% | +37.0% | +30.2% | -34.6% | +13.3% | +20.0% | +0.9% | +5.8% | +37.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -66.7% | – | – | -25.0% | -33.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +250.5% | -32.8% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.